A structured, blended learning program towards proficiency in epileptology: the launch of the ILAE Academy Level 2 Program

A structured, blended learning program towards proficiency in epileptology: the launch of the ILAE Academy Level 2 Program.
International League Against Epilepsy (ILAE) curriculum in epileptology e-learning Level 2 program

Journal

Epileptic disorders : international epilepsy journal with videotape
ISSN: 1950-6945
Titre abrégé: Epileptic Disord
Pays: United States
ID NLM: 100891853

Informations de publication

Date de publication:
01 10 2022
Historique:
entrez: 8 7 2022
pubmed: 9 7 2022
medline: 14 7 2022
Statut: ppublish

Résumé

The ILAE Academy is the online learning platform of the International League Against Epilepsy (ILAE) and offers a structured educational program addressing the competency-based ILAE curriculum in epileptology. The platform was launched in July 2020 with a self-paced course portfolio of interactive e-learning modules addressing ILAE Level 1 learning objectives, defined as the entry level in epileptology. Using feedback questionnaires from completed Level 1 courses as well as sociodemographic and learning-related data obtained from 47 participants, we show that over 50% of learners have an entry level in epileptology and do not have access to on-site training and over 40%do not have access to on-site training. Most respondents found the case-based e-learning modules relevant to their practice needs, and the time for completion was regarded as viable for most, reiterating the value of an online self-paced training in the field. Participants who have successfully completed all compulsory e-learning material of the Level 1 program and received their final certificate will now be eligible to subscribe to the Level 2 program. The Level 2 program addressing the proficiency level of the ILAE curriculum of epileptology was launched on the ILAE Academy platform in May 2022. The Level 2 program will offer an evolving series of self-paced, interactive, case-based e-learning modules on diagnosis, treatment, and counseling of common as well as rare epilepsies at a higher level of care. An interactive online EEG and MRI reader was developed and is embedded into the course content to satisfy the demands of the learners. The hallmark of this level will be the blended learning with tutored online courses, e.g., the established VIREPA courses on EEG and the newly introduced VIREPAMRI program. Our distinguished faculty willhold live tutored online courses in small groups in various languages and continental time zones. Finally, the ILAE face-to-face curricular teaching courses at summer schools and congresses will represent another pillar of this advanced teaching level. The ILAE Academy will also provide Continuing Medical Education (CME) credits to support career planning in epileptology.

Identifiants

pubmed: 35801962
doi: 10.1684/epd.2022.1462
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

737-750

Auteurs

Ingmar Blümcke (I)

Department of Neuropathology, University Hospital Erlangen, Erlangen, Germany, Member of the ERN EpiCARE

Eva Biesel (E)

Baden-Baden, Germany
ILAE Academy, USA

Svenja Bedenlier (S)

Department of Education / Innovation in Learning Institute, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany

Marion Händel (M)

Department of Psychology, Friedrich-Alexander-Universität Erlangen-Nürnberg, Germany. Marion Händel is now at the Department of Psychology, University of Augsburg, Germany

Jo Wilmshurst (J)

Department of Paediatric Neurology, Red Cross War Memorial Childrens Hospital, Neuroscience Institute, University of Cape Town, South Africa

Man Mohan Mehndiratta (MM)

Department of Neurology, B.L. Kapur Hospital (Max Health Care Group), Centre for Neurosciences, Pusa Road, New Delhi-110005, India

Elza Márcia Yacubian (EM)

Department of Neurology and Neurosurgery, Universidade Federal de São Paulo, São Paulo, Brazil

Fernando Cendes (F)

Department of Neurology, School of Medical Sciences, University of Campinas - UNICAMP; and the Brazilian Institute of Neuroscience and Neurotechnology (BRAINN), Campinas, SP, Brazil

Alexis Arzimanoglou (A)

Department of Paediatric Clinical Epileptology, Sleep Disorders and Functional Neurology, University Hospitals of Lyon (HCL), Member of the ERN EpiCARE, Lyon, France; Epilepsy Research, Children’s Hospital San Juan de Dios, Member of the ERN EpiCARE, Barcelona, Spain

Sandor Beniczky (S)

Department of Clinical Neurophysiology, Danish Epilepsy Centre, Affiliated Partner of the ERN EpiCARE, and Aarhus University Hospital, Denmark; Department of Clinical Medicine, Aarhus University, Aarhus, Denmark

Peter Wolf (P)

Danish Epilepsy Centre Filadelfia, Dianalund, Denmark, and Vilnius University, Faculty of Medicine, Institute of Clinical Medicine, Clinic of Neurology and Neurosurgery, Lithuania

Christina Giavasi (C)

Department of Neurology, North Bristol NHS trust, Bristol, UK

Sallie Baxendale (S)

Department of Clinical & Experimental Epilepsy, University College London, Queen Square, Institute of Neurology, London, United Kingdom

Priscilla Shisler (P)

ILAE Academy, USA

Samuel Wiebe (S)

Department of Clinical Neurosciences, Cumming School of Medicine, University of Calgary, Canada

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH